KUALA LUMPUR: Inari Amertron Bhd remains largely optimistic for the rest of the financial year ending June 30, 2025 (FY25) but sees a highly uncertain outlook for FY26. “While the group broadly ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) has been given a consensus rating of “Hold” by the fourteen research firms that are currently covering the company, MarketBeat reports.

Stryker (SYK) announced that it has completed the acquisition of Inari Medical (NARI), a company that provides innovative solutions for venous thromboembolism, or VTE, clot removal without the use ...

Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical ...